It might counteract creatine in regards to intermittent maximal muscle contraction as assessed by leg extension, but the evidence is limited to one study. Additionally, when measuring performance (sprints, usually) where repeated short-term muscle contractions are the concern there is no difference between creatine or creatine+caffeine.
It does not seem to contradict any effects on anaerobic cardio (HIIT) and seems to actually be quite additive in its benefits on performance.
In active males, caffeine (5mg/kg bodyweight once daily at breakfast) coingestion with Creatine (0.5g/kg bodyweight over 8 doses) does not appear to matter in regards to muscular creatine content, but differences are noted on intermittent force production where creatine was significantly greater than placebo (0.5g/kg maltodextrin), but creatine + caffeine was not.
'Intermittent Force Production', in accordance with the prior study, is depicted below. Three overall 'bouts' of exercise descending from a triplet (3 sets) of 30 reps with 60 seconds rest, 4 sets of 20 reps with 40 seconds rest in between each one, and finally 5 sets of 10 reps with 20 seconds rest in between. 2 minutes rest between each of the three bouts. Each rep was to be a Maximal Voluntary Contraction (MVC)
B group is creatine supplementation, whereas C is creatine + caffeine.
In high intensity exercise (125% VO2 max running) when subjects loaded for 6 days with 0.3g/kg bodyweight, a one-time acute load of 5mg/kg bodyweight caffeine does not appear to impair the effects of creatine supplementation on HIIT and exerts its own effects; the end result is that creatine + caffeine outperforms creatine alone and placebo.
These results have been replicated with 10 second sprints on a cycling device, in which creatine was loaded for 6 days (at 0.3g/kg) and then acute ingestion of caffeine at 6mg/kg bodyweight outperformed the group that then received the acute placebo, a pre-workout supplement consisting of creatine and caffeine (with amino acids) seems to be effective independent of loading when taken before high intensity exercise, but doesn't tend to increase longer aerobic exercise.
Related Nutrition Articles
- How much caffeine is too much?
- The science behind caffeine
- Do I need to cycle ephedrine?
- Do I need to cycle caffeine?
- The downsides of caffeine intake
- How does caffeine work in your brain?
- Ten tips for better sleep
- Are energy drinks bad for you?
- Do you need to cycle creatine?
- Can creatine cause cancer?
- Does creatine benefit elite athletes?
- Is creatine safe for your kidneys?
- Does creatine cause hair loss?
- When should I take creatine?
- What is creatine nitrate?
- Can creatine increase your testosterone levels?
- Do I need to load creatine?
- Is creatine a steroid?
- What beneficial compounds are primarily found in animal products?
- What is the best form of creatine?
- Is creatine safe?
- What happens if I go off of creatine?
- Caffeine counteracts the ergogenic action of muscle creatine loading . J Appl Physiol. (1996) Vandenberghe K, et al.
- Caffeine is ergogenic after supplementation of oral creatine monohydrate . Med Sci Sports Exerc. (2002) Doherty M, et al.
- Effect of caffeine ingestion after creatine supplementation on intermittent high-intensity sprint performance . Eur J Appl Physiol. (2011) Lee CL, Lin JC, Cheng CF.
- The possible combinatory effects of acute consumption of caffeine, creatine, and amino acids on the improvement of anaerobic running performance in humans . Nutr Res. (2010) Fukuda DH, et al.
- The effects of a pre-workout supplement containing caffeine, creatine, and amino acids during three weeks of high-intensity exercise on aerobic and anaerobic performance . J Int Soc Sports Nutr. (2010) Smith AE, et al.
- Ingesting a pre-workout supplement containing caffeine, B-vitamins, amino acids, creatine, and beta-alanine before exercise delays fatigue while improving reaction time and muscular endurance . Nutr Metab (Lond). (2012) Spradley BD, et al.
- Creatine and caffeine in anaerobic and aerobic exercise: effects on physical performance and pharmacokinetic considerations . Int J Clin Pharmacol Ther. (1998) Vanakoski J, et al.